Pfizer could split after its merger with Allergan fails
Pfizer’s chief executive has said a decision on whether to break up the company will be made by the end of the year after its $US160billion ($210 billion) merger with Allergan collapsed.
Ian Read said a decision to split the American company by selling off its lower-margin unit of older products facing generic competition would be taken "no later than the end of 2016".
Pfizer and Allergan walked away from their multi-billion dollar merger agreement on Tuesday, blaming the US Treasury for the collapse of what would have marked the largest ever healthcare acquisition. Sydney Morning Herald – Read more…
Ian Read said a decision to split the American company by selling off its lower-margin unit of older products facing generic competition would be taken "no later than the end of 2016".
Pfizer and Allergan walked away from their multi-billion dollar merger agreement on Tuesday, blaming the US Treasury for the collapse of what would have marked the largest ever healthcare acquisition. Sydney Morning Herald – Read more…
Recent Posts
